One of the newer opioids to hit the market has a better pain relief and safety profile in patients with chronic musculoskeletal pain than oxycodone, a Cochrane review finds. But its overall clinical benefit of in terms of pain reduction is still probably small, say the review authors from the Pain, Palliative and Supportive Care Group. The ...
Small clinical benefit for new opioid
1 Jun 2015